Results 281 to 290 of about 156,514 (326)

Bioengineered Isoflavone–Probiotic Functional Foods for Sustainable Modulation of Metabolic and Reproductive Health in PCOS

Food Bioengineering, EarlyView.
Synergistic isoflavone‐probiotic action modulated metabolic, microbial and ovarian pathway ABSTRACT Polycystic ovary syndrome (PCOS) is a prevalent metabolic–endocrine disorder characterized by insulin resistance, hyperandrogenism, chronic inflammation, oxidative stress, and ovarian dysfunction, with growing evidence implicating gut microbiota ...
Jeyavelkumaran Renukadevi, Panneerselvam Sneha, Dhanapal Saravanan Mridula, Keerthivasan Nimithasree, Valliappan Sanjay   +4 more
wiley   +1 more source

What should constitute a control condition in psychedelic drug trials? [PDF]

Nat Ment Health
Colloca L, Fava M.
europepmc   +1 more source

Acceptance of Open-Label Placebos Is Linked to Holistic Health Beliefs and Thinking Styles

Arved Seibel, Albert Wabnegger, Anne Schienle   +2 more
openalex   +1 more source

Antibody-Based Therapeutics for Hypercholesterolemia. [PDF]

Biologics
Tomlinson B, Chan P.
europepmc   +1 more source

Nephrological perspectives on the underutilization of SGLT2is in heart failure and chronic kidney disease

ESC Heart Failure, Volume 12, Issue 2, Page 1490-1491, April 2025.
Özant Helvacı, Ömer Faruk Akçay, Emre Yaşar, Ülver Derici, Galip Güz   +4 more
wiley   +1 more source

Addressing blinding in classic psychedelic studies with innovative active placebos. [PDF]

Int J Neuropsychopharmacol
Aday JS, Simonsson O, Schindler EAD, D'Souza DC.   +3 more
europepmc   +1 more source

Placebo and nocebo in clinical practice: An online cross-sectional survey of healthcare professionals from European countries on views, practices and training needs. [PDF]

PLoS One
O'Keeffe M, Skidmore N, Bagnis A, Bąbel P, Bajcar EA, De Palma A, Evers AWM, Glogan E, Haas JW, Meeuwis SH, Oleszczyk M, Portolés A, Vlaeyen JWS, Mattarozzi K, PANACEA Consortium.   +14 more
europepmc   +1 more source

Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis. [PDF]

Curr Oncol
Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Choice over placebo administration enhances open-label placebo hypoalgesia.

Pain, 2023
Many studies indicate that deceptively administered placebos can improve pain outcomes. However, the deception involved presents an ethical barrier to translation because it violates informed consent and patient autonomy.
Biya Tang, Evan J. Livesey, Ben Colagiuri   +2 more
semanticscholar   +3 more sources

Deceptive but not open label placebos attenuate motion-induced nausea.

Journal of Psychosomatic Research, 2019
Nausea is a common complaint, known to respond to the placebo effect. Existing research has employed deception when administering placebos for nausea, limiting therapeutic translation on ethical grounds. We therefore examined the potential of non-deceptive open-label placebos (OLPs) to reduce nausea.Galvanic Vestibular Stimulation (GVS) and Virtual ...
K. Barnes, A. Yu, J. Josupeit, B. Colagiuri   +3 more
semanticscholar   +3 more sources